The updated 2020 Elections Toolkit for Action includes links to IDSA and the Brennan Center Guidelines for Healthy In-Person Voting, background on IDSA and HIVMA policy recommendations and the health professional VoteHealth2020 coalition’s resources
From the Factory to the Frontlines, the strategy for distributing a COVID-19 vaccine released by the Department of Health and Human Services Thursday, reflects commitment to important approaches to controlling this pandemic.
“The return to a science-based based approach to testing guidance from the Centers for Disease Control and Prevention is good news for public health and for our united fight against this pandemic. We urge officials to support the work of controlling this pandemic by following medical guidance of experts in the field.”
Thomas File, M.D., FIDSA – President, Infectious Diseases Society of America
The U.S. Food and Drug Administration’s order changing the classification for tests used to measure cytomegalovirus loads in transplant patients is an important step in improving and making more accessible a critical tool for patient care management.
In a letter to U.S. Food and Drug Administration leaders today, more than 90 organizations representing physicians and other health providers, as well as scientists, patients and medical advocates, urge the agency to ensure that reviews of COVID-19 vaccine candidates meet all regulatory standards prior to authorization or licensure.
Members of the Infectious Diseases Society of America and its HIV Medicine Association across the country are on the front lines of COVID-19 responses in their communities. IDSA is proud to support their work in advancing research into COVID-19 and in development of data-driven, evidence-based research practices and responses